
The European Union’s antitrust regulators are investigating the pricing practices of fashion companies, including Kering’s Gucci, who were subject to raids in April. The focus is on the pricing of handbags and leather goods for distributors, according to three individuals with firsthand information who spoke to Reuters.
At the time, Kering confirmed that Gucci was working with EU regulators following a reported dawn raid on its Milan site by the European Union, where such products are made.
Neither the European Commission nor Kering provided a comment on Monday.
Related: EU Watchdog Raids Fashion Firms In Cartel Probe
The Commission did not disclose the names of the companies it conducted raids on. It stated they may have violated EU antitrust regulations pertaining to cartels and restrictive business practices but refrained from giving further information.
The EU competition watchdog is conducting an investigation regarding possible price-fixing by companies on multi-brand retailers. The investigation includes examining if the companies are threatening to withhold their products from retailers who do not comply with their pricing policies.
Engaging in such practices is prohibited by EU antitrust rules, and violations may result in fines of up to 10 percent of the company’s worldwide revenue.
Guess, a clothing company based in the US, received a fine of €40 million ($43 million) in 2018 for breaching regulations that prohibit retailers from setting their own retail prices for its products.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas